At the transcriptional level, GCN2/ATF4 signaling can modulate the expression of endothelin-1 (ET-1), a potent vasoconstrictor involved in pulmonary hypertension. This evidence concerns the gene EIF2AK4 and pulmonary arterial hypertension.